An in-depth look to BRIM BIOTECHNOLOGY INC operating, investing, and financing activities

6885 free cash flow for Q3 24 is -53.28 M TWD. For 2023, 6885 free cash flow was -599.15 M TWD and operating cash flow was -596.89 M TWD.